SVRE (SVRE) Stock Price & Analysis
SVRE (SVRE) fell 4.04% to USD 3.56 as of July 25, 2026 at 06:54 UTC, according to Nexqual real-time market data.
SVRE last closed at USD 3.71; the session ranged USD 3.36–3.75 on volume of 35,340 shares. Market capitalization is $5.92M, with a 52-week range of USD 2.02–31.08 (NCM). Source: Nexqual, July 25, 2026 at 06:54 UTC.
Key Statistics (as of July 25, 2026 at 06:54 UTC)
| Price | USD 3.56 |
|---|---|
| Change | ▼ 4.04% (down) |
| Previous Close | USD 3.71 |
| Open | USD 3.54 |
| Day Range | USD 3.36 – 3.75 |
| 52-Week Range | USD 2.02 – 31.08 |
| Volume | 35,340 shares |
| Market Cap | $5.92M |
| Exchange | NCM |
Technical Analysis (SVRE)
Nexqual's technical model rates SVRE "NEUTRAL" based on 3 bullish and 3 bearish signals across 125 daily candles, as of July 25, 2026 at 06:54 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 58.53 (neutral) |
| vs SMA50 | Below (USD 3.62) |
| MACD | -0.03 (negative) |
Analyst Ratings (SVRE)
Wall Street analysts rate SVRE "None", per Nexqual as of July 25, 2026 at 06:54 UTC.
| Consensus Rating | None |
|---|
Earnings (SVRE)
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Financials & Fundamentals (SVRE)
| Revenue Growth (YoY) | -78.30% |
|---|---|
| Gross Margin | -143.90% |
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -257.45% |
| Debt / Equity | 42.12 |
| Current Ratio | 2.34 |
| Free Cash Flow | $-17.66M |
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Financial Health Score (SVRE)
Nexqual rates SVRE's overall financial health "Weak" across five dimensions, as of July 25, 2026 at 06:54 UTC.
| Growth | Critical — Revenue -38% YoY (annual), sharp decline |
|---|---|
| Profitability | Weak — Pre-revenue or very early stage |
| Balance Sheet | Strong — Debt/Equity 0.4x |
| Cash Flow | Weak — FCF negative: -$18M, burning cash |
| Efficiency | Critical — ROE -257%, ROA -85.9% |
Ownership (SVRE)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +2.81% |
| Shares Outstanding | 1.66M |
| Float | 93,682 |
| Short % of Float | +2.07% |
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Leadership (SVRE)
SVRE is led by Ori Gilboa (age 61), CEO & Director, per Nexqual as of July 25, 2026 at 06:54 UTC.
| CEO & Director | Ori Gilboa (age 61) |
|---|---|
| Founder & COO | Yossi Cohen (age 58) |
| Chief Financial Officer | Meital Nevo (age 43) |
Major Backers & Investors (SVRE)
Notable institutional backers of SVRE include Rhumbline Advisers, Smartharvest Portfolios, LLC, according to Nexqual as of July 25, 2026 at 06:54 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Rhumbline Advisers | 6.33% |
| Smartharvest Portfolios, LLC | 1.2% |
Source: Nexqual, July 25, 2026 at 06:54 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| SPRC | SciSparc Ltd. | USD 5.33 | ▲ 10.12% |
| FRGT | Freight Technologies, Inc. | USD 3.01 | ▼ 15.45% |
| ILAG | Intelligent Living Application | USD 3.45 | ▼ 0.23% |
| BBLG | Bone Biologics Corp | USD 1.07 | ▼ 2.73% |
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.12 | ▼ 1.69% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 06:54 UTC. This page is informational and not investment advice.